Biodefense: Opportunities to Address National Strategy and Programmatic Challenges, Statement of Chris P. Currie, Director, Homeland Security and Justice, Testimony Before the Committee on Homeland Security and Governmental Affairs, U.S. Senate [open pdf - 532KB]
From the Highlights: "Biological threats, such as the COVID-19 [coronavirus disease 2019] pandemic, can cause catastrophic loss of life and damage to the economy. The 2018 National Biodefense Strategy outlines goals and objectives to help prepare for and respond to such threats. However, DHS has long faced challenges implementing its biodefense responsibilities, including acquiring biodetection capabilities. This statement discusses GAO [Government Accountability Office] reports issued from December 2009 through August 2021 on efforts to implement the National Biodefense Strategy and strengthen biodefense preparedness, as well as ongoing challenges to DHS's biosurveillance and biodetection efforts. The statement also includes recommendation follow-up work conducted through January 2022."
Government Accountability Office: https://www.gao.gov/